시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 성병(STD) 자가검사 시장 보고서(2025년)
Sexually Transmitted Disease (STD) Self-Testing Global Market Report 2025
상품코드 : 1811026
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,362,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,196,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,031,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 성병(STD) 자가검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 연평균 복합 성장률(CAGR) 9.8%로 확대되어 22억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 성병의 유병률 증가, 개인적이고 편리한 검사 방법에 대한 선호도 증가, 자가검사 키트에 디지털 건강 기능의 통합 진전, 개발 도상 지역에서의 가정 내 진단의 광범위한 가용성, 고급 자가검사 기술의 규제 허가 증가로 인한 것으로 예측됩니다. 이 기간에 예상되는 주요 동향으로는 신속 분자진단 도구의 진보, 결과 추적을 위한 모바일 앱 통합 강화, 여러 감염을 감지하는 자가검사 키트 생성, 눈에 띄지 않는 포장 및 전달 솔루션 혁신, 검사 결과 AI 주도 분석의 발전 등이 있습니다.

매독 환자 수 증가는 성병(STD) 자가검사 시장의 성장에 기여하고 있습니다. 매독은 성행위에 의해 감염되는 감염으로, 치료하지 않으면 상처를 유발하고 심각한 건강 합병증을 유발할 수 있습니다. 매독 감염 증가는 특히 위험이 높은 성행위를 하는 사람들 사이에서 콘돔의 일관된 사용이 감소하는 것이 주요 원인입니다. STD 자가검사는 개인이 집에서 검사할 수 있는 개인적이고 편리한 방법으로 조기 진단을 촉구합니다. 조기 발견은 시기 적절한 치료로 이어지고 합병증의 위험을 줄이고 감염의 확산을 예방하는 데 도움이 됩니다. 예를 들어, 미국 질병 예방 관리 센터(CDC)에 따르면 2023년에 보고된 매독 사례는 약 20만 9,253건으로 2022년에 보고된 20만 7,269건에서 1% 증가했습니다. 이 유병률 증가는 자가검사 솔루션 수요를 밀어 올리고 있습니다.

성병(STD) 자가검사 시장의 신흥국 시장은 조기진단과 치료를 지원하기 위해 시판(OTC) 샘플 채취 키트 등의 혁신적인 제품을 개발하고 있습니다. 이러한 OTC 키트는 개인이 집에서 처방전 없이 소변이나 면봉과 같은 샘플을 채취할 수 있게 하고 감염을 확인하는 겸손하고 사용하기 쉬운 방법을 설명합니다. 2023년 8월 미국의 디지털 건강 기업인 iHealth Labs Inc.는 HIV와 매독 검사용 CheckMeSafe 홈 컬렉션 키트를 발표했습니다. 이 FDA 허가 키트는 18세 이상의 개인이 HIV(i형, ii형, P24 항원)와 매독을 검사하기 위한 혈액 샘플을 집에서 채취할 수 있습니다. 시료는 선불 야간 배송 라벨을 사용하여 검사 기관에 우송할 수 있으며, 최소 2일 후에 비밀 결과를 얻을 수 있습니다. 이 키트는 HIV의 경우 99.9%, 매독의 경우 99.5%의 감도로 매우 정확한 결과를 제공합니다. 모든 검사는 CLIA 인증 및 CAP 인증 실험실에서 처리되며 연방 및 주 품질 규제를 충족합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Sexually transmitted disease (STD) self-testing involves individuals collecting their own samples to screen for STDs without visiting a clinical facility. This approach offers a private, convenient, and prompt way to detect infections such as chlamydia, gonorrhea, HIV, and syphilis through at-home kits or mail-in laboratory services.

The primary types of STD self-testing samples include blood-based, urine-based, and oral-based tests. Blood-based self-tests typically use a small blood sample from a finger prick to effectively identify infections like HIV, syphilis, and hepatitis in their early stages. These tests are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are used for multiple purposes such as chlamydia trachomatis (CT) or Neisseria gonorrhoeae (NG) detection, syphilis screening, HIV testing, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The sexually transmitted disease (STD) self-testing market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted disease (STD) self-testing market statistics, including the sexually transmitted disease (STD) self-testing industry global market size, regional shares, competitors with the sexually transmitted disease (STD) self-testing market share, detailed sexually transmitted disease (STD) self-testing market segments, market trends, opportunities, and any further data you may need to thrive in the sexually transmitted disease (STD) self-testing industry. This sexually transmitted disease (STD) self-testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sexually transmitted disease (STD) self-testing market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historical period can be linked to greater awareness of sexual health, increased adoption of home-based healthcare options, the expansion of government-supported STD screening programs, wider accessibility of over-the-counter self-testing kits, and growing concerns over privacy associated with clinic-based testing.

The sexually transmitted disease (STD) self-testing market size is expected to see strong growth in the next few years. It will grow to $2.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to the rising prevalence of sexually transmitted infections, increasing preference for private and convenient testing methods, greater integration of digital health features in self-testing kits, broader availability of at-home diagnostics in developing regions, and growing regulatory approval of advanced self-testing technologies. Key trends expected during this period include progress in rapid molecular diagnostic tools, enhanced mobile app integration for tracking results, the creation of self-test kits that detect multiple infections, innovations in discreet packaging and delivery solutions, and advancements in AI-driven analysis of test outcomes.

The increasing number of syphilis cases is contributing to the growth of the sexually transmitted disease (STD) self-testing market. Syphilis is a sexually transmitted infection that causes sores and can result in severe health complications if untreated. The rise in syphilis infections is largely attributed to a decline in consistent condom use, especially among individuals involved in high-risk sexual behavior. STD self-testing offers a private and convenient method for individuals to screen themselves at home, encouraging early diagnosis. Early detection leads to timely treatment, reducing the risk of complications and helping prevent the spread of infection. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 209,253 syphilis cases were reported in the United States in 2023, a 1% increase from the 207,269 cases reported in 2022. This growing prevalence is boosting the demand for self-testing solutions.

Companies in the STD self-testing market are developing innovative products like over-the-counter (OTC) sample collection kits to support early diagnosis and treatment. These OTC kits allow individuals to collect samples such as urine or swabs at home without a prescription, offering a discreet and user-friendly way to identify infections. In August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit enables individuals aged 18 and older to collect blood samples from home for testing HIV (types I, II, P24 antigen) and syphilis. Samples can be mailed to a laboratory using a prepaid overnight shipping label, with confidential results available in as little as two days. The kit delivers highly accurate outcomes, with sensitivity levels of up to 99.9% for HIV and 99.5% for syphilis. All tests are processed in a CLIA-certified and CAP-accredited lab, ensuring they meet federal and state quality regulations.

In December 2024, OraSure Technologies Inc., a US-based company that offers point-of-need and home diagnostic tests, acquired Sherlock Biosciences for an undisclosed amount. This acquisition is intended to expand OraSure's presence in the at-home diagnostics market by incorporating Sherlock Biosciences' CRISPR-based molecular technology. The integration of this advanced technology aims to create rapid, over-the-counter self-tests for STDs such as chlamydia and gonorrhea. These tests are designed to provide lab-quality results at home within minutes, making accurate and private STD testing more accessible. Sherlock Biosciences is a US-based company engaged in clinical trials for rapid OTC diagnostics for sexually transmitted infections.

Major players in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.

North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted disease (STD) self-testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted disease (STD) self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted disease (STD) self-testing market consists of revenues earned by entities by providing services such as telehealth consultations, digital result delivery, follow-up care coordination, and online pre-test counselling. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted disease (STD) self-testing market includes sales of sample collection devices, buffer solutions or reagents, at-home diagnostic kits, mobile app-based test tracking tools, and smartphone-compatible test devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sexually Transmitted Disease (STD) Self-Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted disease (std) self-testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sexually transmitted disease (std) self-testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sexually transmitted disease (std) self-testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sexually Transmitted Disease (STD) Self-Testing Market Characteristics

3. Sexually Transmitted Disease (STD) Self-Testing Market Trends And Strategies

4. Sexually Transmitted Disease (STD) Self-Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sexually Transmitted Disease (STD) Self-Testing Growth Analysis And Strategic Analysis Framework

6. Sexually Transmitted Disease (STD) Self-Testing Market Segmentation

7. Sexually Transmitted Disease (STD) Self-Testing Market Regional And Country Analysis

8. Asia-Pacific Sexually Transmitted Disease (STD) Self-Testing Market

9. China Sexually Transmitted Disease (STD) Self-Testing Market

10. India Sexually Transmitted Disease (STD) Self-Testing Market

11. Japan Sexually Transmitted Disease (STD) Self-Testing Market

12. Australia Sexually Transmitted Disease (STD) Self-Testing Market

13. Indonesia Sexually Transmitted Disease (STD) Self-Testing Market

14. South Korea Sexually Transmitted Disease (STD) Self-Testing Market

15. Western Europe Sexually Transmitted Disease (STD) Self-Testing Market

16. UK Sexually Transmitted Disease (STD) Self-Testing Market

17. Germany Sexually Transmitted Disease (STD) Self-Testing Market

18. France Sexually Transmitted Disease (STD) Self-Testing Market

19. Italy Sexually Transmitted Disease (STD) Self-Testing Market

20. Spain Sexually Transmitted Disease (STD) Self-Testing Market

21. Eastern Europe Sexually Transmitted Disease (STD) Self-Testing Market

22. Russia Sexually Transmitted Disease (STD) Self-Testing Market

23. North America Sexually Transmitted Disease (STD) Self-Testing Market

24. USA Sexually Transmitted Disease (STD) Self-Testing Market

25. Canada Sexually Transmitted Disease (STD) Self-Testing Market

26. South America Sexually Transmitted Disease (STD) Self-Testing Market

27. Brazil Sexually Transmitted Disease (STD) Self-Testing Market

28. Middle East Sexually Transmitted Disease (STD) Self-Testing Market

29. Africa Sexually Transmitted Disease (STD) Self-Testing Market

30. Sexually Transmitted Disease (STD) Self-Testing Market Competitive Landscape And Company Profiles

31. Sexually Transmitted Disease (STD) Self-Testing Market Other Major And Innovative Companies

32. Global Sexually Transmitted Disease (STD) Self-Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Disease (STD) Self-Testing Market

34. Recent Developments In The Sexually Transmitted Disease (STD) Self-Testing Market

35. Sexually Transmitted Disease (STD) Self-Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기